Clinical Trial Update: Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial assessing sequential S-1 chemotherapy followed by Serplulimab after concurrent chemoradiotherapy in locally advanced, inoperable esophageal squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• Serplulimab (serplulimab)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING